|
| Guest
lectures arranged in alphabetical order by the presenter's surname
|
Overview
of steroidogenic isoenzymes
S. Andersson, Dallas, Texas, USA (S 1) |
Lessons
to be learned from the androgen receptor
A.O. Brinkmann, Rotterdam, The Netherlands (S 3) |
A
practical approach to hirsutism
F. Camacho, Seville, Spain (LS 1) |
Events
during skin appendage development
C.-M. Chuong, Los Angeles, USA (L 1) |
Comparing
the morphology of hair, feather and teeth development
C.-M. Chuong, Los Angeles, California, USA (C 3) |
|
Closing
lecture: The hair follicle as a target for gene therapy
G. Cotsarelis, Philadelphia, USA (L 5)
|
Enzymology
of the hair follicle
R. Hoffmann, Marburg, Germany (S 2) |
|
Closing
lecture: Treatment of autoimmunity: Future perspectives
T. Luger, Münster, Germany (L 3)
|
Susceptibility
genes of balding men versus non-balding men
A. Messenger, Sheffield, UK (S 5) |
Hair
growth and hair loss: A technical challenge for the clinician
D. van Neste, Tournai, Belgium (S 8) |
Histology
of the murine hair cycle
R. Paus, Hamburg, Germany
S. Müller-Röver, London, UK (C 2) |
Soluble
factors involved in androgen-mediated effects on the hair follicle
V. Randall, Bradford, UK (S 6) |
Management
of diffuse hair loss in women
H. Rushton, London, UK
(LS 2) |
Androgen
responsive genes as they affect hair growth
M. Sawaya, Ocala, Florida, USA (S 4) |
|
The
child with funny hair
R. Sinclair, Melbourne, Australia (LS 3)
|
Introductory
lecture: Genes and hair
P.M. Steijlen, Nijmegen, The Netherlands (L 4) |
Critical
review of hair removal approaches
W. Stolz, M. Wimmershoff, U. Hohenleutner, Regensburg, Germany
(LS 5) |
Morphology
of hair in inbred mouse mutants
J.P. Sundberg, Bar Harbor, Maine, USA (C 1) |
Androgenetic
alopecia: in vivo models
J. P. Sundberg, Bar Harbor, Maine, USA (S 7) |
Clinical
update on use of topical minoxidil solution
R.J. Trancik, Bridgewater, USA (S 12) |
|
The
value of hair cosmetics and pharmaceuticals
R. M. Trüeb, Zürich, Switzerland (LS 4)
|
Histopathology
of alopecia in horizontal sections
D. Whiting, Dallas, Texas, USA (C 4) |
Treatment
of androgenetic alopecia: The finasteride experience
D. Whiting, Dallas, Texas, USA (S 9) |
Minoxidil,
the story of an adverse effect that became a new indication
D. Whiting, Dallas, USA (S 10) |
Topical
minoxidil solution 5% in the treatment of androgenetic alopecia
in males
H. Wolff, Munich, Germany (S 11) |
Management
of scarring alopecias
H. Wolff, Munich, Germany (LS 6) |
Introductory
lecture: The role of T and dendritic cells in autoimmunity
M. Zöller, Heidelberg, Germany (L 2) |
